DOI QR코드

DOI QR Code

Value of Postoperative Radiation Therapy for Regional Control after Dissection in Head and Neck Squamous Cell Carcinoma Cases

  • Li, Xiao-Ming (Department of Otorhinolaryngology Head and Neck Surgery, Bethune International Peace Hospital) ;
  • Di, Bin (Department of Otorhinolaryngology Head and Neck Surgery, Bethune International Peace Hospital) ;
  • Shang, Yao-Dong (Department of Otorhinolaryngology Head and Neck Surgery, Bethune International Peace Hospital) ;
  • Tao, Zhen-Feng (Department of Otorhinolaryngology Head and Neck Surgery, Bethune International Peace Hospital) ;
  • Cheng, Ji-Min (Department of Pathology, Bethune International Peace Hospital) ;
  • He, Zhan-Guo (Department of Pathology, Bethune International Peace Hospital)
  • Published : 2013.07.30

Abstract

Objective: We aimed to define clinicopathologic risk factors associated with regional recurrence (RR) and thus the effectiveness of postoperative radiotherapy (PORT) for neck control for head and neck squamous cell carcinomas (HNSCCs) with differing cervical lymph node status. Methods: A retrospective study was performed in 196 HNSCC patients with pathologically positive neck node (N+) to evaluate the high-risk factors for RR and to define the role of PORT in control after neck dissection and postoperative radiotherapy (PORT). Results: Overall, the RR rate after neck dissection and PORT was 29%. Extracapsular spread (ECS) was confirmed to be the only independent risk factor for RR. There were no significant risk factors associated with RR in the ECS- group. The 5-year disease-specific survival rate was 45%, which descended to 10% with the emergence of RR. Conclusions: ECS remains a determined risk factor for RR after neck dissection and PORT in patients with N+. PORT alone is not adequate for preventing RR in the neck with ECS after neck dissection. More intensive postoperative adjuvant therapies, especially combined chemotherapy and radiotherapy, are needed to prevent regional failure in HNSCC patients with ECS.

Keywords

References

  1. Barzan L, Talamini R (1996). Analysis of prognostic factors for recurrence after neck dissection. Arch Otolaryngol Head Neck Surg, 122, 1299-302. https://doi.org/10.1001/archotol.1996.01890240009003
  2. Buck G, Huguenin P, Stoeckli SJ (2008). Efficacy of neck treatment in patients with head and neck squamous cell carcinoma. Head Neck, 30, 50-7. https://doi.org/10.1002/hed.20657
  3. Clark J, Li W, Smith G, et al (2005). Outcome of treatment for advanced cervical metastatic squamous cell carcinoma. Head Neck, 27, 87-94. https://doi.org/10.1002/hed.20129
  4. Cooper JS, Pajak TF, Forastiere AA, et al (2004). Radiation Therapy Oncology Group 9501/Intergroup. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med, 350, 1937-44. https://doi.org/10.1056/NEJMoa032646
  5. Deschamps DR, Spencer HJ, Kokoska MS, et al (2010). Implications of head and neck cancer treatment failure in the neck. Otolaryngol Head Neck Surg, 142, 722-7. https://doi.org/10.1016/j.otohns.2010.01.026
  6. Hanai N, Kawakita D, Ozawa T, et al (2013). Neck dissection after chemoradiotherapy for oropharyngeal and hypopharyngeal cancer: the correlation between cervical lymph node metastasis and prognosis. Int J Clin Oncol, DOI 10.1007/ s10147-013-0518-9 [Epub ahead of print].
  7. Jackel MC, Ambrosch P, Christiansen H, et al (2008). Value of postoperative radiotherapy in patients with pathologic N1 neck diseases. Head Neck, 30, 875-82. https://doi.org/10.1002/hed.20794
  8. Jones AS, Tandon S, Helliwell TR, et al (2008). Survival of patients with neck recurrence following radical neck dissection: utility of a second neck dissection? Head Neck, 30, 1514-22. https://doi.org/10.1002/hed.20860
  9. Kang CJ, Lin CY, Wang HM, et al (2011). The number of pathologically positive lymph nodes and pathological tumor depth predicts prognosis in patients with poorly differentiated squamous cell carcinoma of the oral cavity. Int J Radiat Oncol Biol Phys, 81, e223-30. https://doi.org/10.1016/j.ijrobp.2011.03.060
  10. Layland MK, Sessions DG, Lenox J (2005). The influence of lymph node metastasis in the treatment of squamous cell carcinoma of oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+. Laryngoscope, 115, 629-39. https://doi.org/10.1097/01.mlg.0000161338.54515.b1
  11. Leemans CR, Tiwari R, van der Waal I, et al (1990). The efficacy of comprehensive neck dissection with or without postoperative radiotherapy in nodal metastases of squamous cell carcinoma of the upper respiratory and digestive tracts. Laryngoscope, 100, 1194-8.
  12. Mendenhall WM, Amdur RJ, Hinerman RW, et al (2003). Postoperative radiation therapy for squamous cell carcinoma of the head and neck. Am J Otolaryngol, 24, 41-50. https://doi.org/10.1053/ajot.2003.1
  13. Nishimura G, Matsuda H, Taguchi T, et al (2012). Treatment evaluation of metastatic lymph nodes after concurrent chemoradiotherapy in patients with head andneck squamous cell carcinoma. Anticancer Res, 32, 595-600.
  14. Peters LJ, Goepfert H, Ang KK, et al (1993). Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial. Int J Radiat Oncol Biol Phys, 26, 3-11. https://doi.org/10.1016/0360-3016(93)90167-T
  15. Peters LJ, Goepfert H, Ang KK, et al (1993). Extracapsular spread and desmoplastic pattern in neck lymph nodes: two prognostic factors of laryngeal cancer. Ann Otol Rhinol Laryngol, 108, 672-6.
  16. Santa-Maria PL, Sader C, Preston NJM, et al (2007). Neck dissection for squamous cell carcinoma of the head and neck. Otolaryngol Head Neck Surg, 136, 41-5. https://doi.org/10.1016/j.otohns.2006.10.024
  17. Schiff PB, Harrison LB, Strong EW, et al (1990). Impact of the time interval between surgery and postoperative radiation therapy on locoregional control in advanced head and neck cancer. J Surg Oncol, 43, 203-8. https://doi.org/10.1002/jso.2930430403
  18. Shingaki S, Takada M, Sasai K, et al (2003). Impact of lymph node metastasis on the pattern of failure and survival in oral carcinomas. Am J Surg, 185, 278- 84. https://doi.org/10.1016/S0002-9610(02)01378-8
  19. Strojan P, Ferlito A, Langendijk JA, et al (2012). Indications for radiotherapy after neck dissection. Head Neck, 34, 113-9. https://doi.org/10.1002/hed.21599
  20. Vaidya AM, Petruzzelli GJ, Clark J, et al (2001). Patterns of spread in recurrent head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg, 125, 393-6. https://doi.org/10.1067/mhn.2001.117715

Cited by

  1. Fenofibrate Increases Radiosensitivity in Head and Neck Squamous Cell Carcinoma via Inducing G2/M Arrest and Apoptosis vol.15, pp.16, 2014, https://doi.org/10.7314/APJCP.2014.15.16.6649
  2. Gibt es Patienten mit Plattenepithelkarzinomen der Kopf-Hals-Region, die von einer Deintensivierung der postoperativen Bestrahlung profitieren könnten? pp.1439-099X, 2019, https://doi.org/10.1007/s00066-018-1415-y